Cargando…

Synthetic antibody-derived immunopeptide provides neuroprotection in glaucoma through molecular interaction with retinal protein histone H3.1

Glaucoma is a group of optic neuropathies characterized by the progressive degeneration of retinal ganglion cells (RGCs) as well as their axons leading to irreversible loss of sight. Medical management of the intraocular pressure (IOP) still represents the gold standard in glaucoma therapy, which on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fomo, Kristian Nzogang, Schmelter, Carsten, Atta, Joshua, Beutgen, Vanessa M., Schwarz, Rebecca, Perumal, Natarajan, Govind, Gokul, Speck, Thomas, Pfeiffer, Norbert, Grus, Franz H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613933/ https://www.ncbi.nlm.nih.gov/pubmed/36313990 http://dx.doi.org/10.3389/fmed.2022.993351

Ejemplares similares

Glaucoma-Associated CDR1 Peptide Promotes RGC Survival in Retinal Explants through Molecular Interaction with Acidic Leucine Rich Nuclear Phosphoprotein 32A (ANP32A)
por: Schmelter, Carsten, et al.
Publicado: (2023)

Synthetic Polyclonal-Derived CDR Peptides as an Innovative Strategy in Glaucoma Therapy
por: Schmelter, Carsten, et al.
Publicado: (2019)

Regulation of the HTRA2 Protease Activity by an Inhibitory Antibody-Derived Peptide Ligand and the Influence on HTRA2-Specific Protein Interaction Networks in Retinal Tissues
por: Schmelter, Carsten, et al.
Publicado: (2021)

Autoantigens in the trabecular meshwork and glaucoma‐specific alterations in the natural autoantibody repertoire
por: Beutgen, Vanessa M, et al.
Publicado: (2020)

Autoantibody Biomarker Discovery in Primary Open Angle Glaucoma Using Serological Proteome Analysis (SERPA)
por: Beutgen, Vanessa M., et al.
Publicado: (2019)

An In-Depth View of the Porcine Trabecular Meshwork Proteome
por: Funke, Sebastian, et al.
Publicado: (2019)

Contribution of the Commensal Microflora to the Immunological Homeostasis and the Importance of Immune-Related Drug Development for Clinical Applications
por: Beutgen, Vanessa M., et al.
Publicado: (2021)

Serological Levels of Anti-clathrin Antibodies Are Decreased in Patients With Pseudoexfoliation Glaucoma
por: Beutgen, Vanessa M., et al.
Publicado: (2021)

A Monoclonal Anti-HMGB1 Antibody Attenuates Neurodegeneration in an Experimental Animal Model of Glaucoma
por: Tonner, Henrik, et al.
Publicado: (2022)

Glaucoma related Proteomic Alterations in Human Retina Samples
por: Funke, Sebastian, et al.
Publicado: (2016)

Lectin-Based Affinity Enrichment and Characterization of N-Glycoproteins from Human Tear Film by Mass Spectrometry
por: Schmelter, Carsten, et al.
Publicado: (2023)

Dynamin-like Protein 1 (DNML1) as a Molecular Target for Antibody-Based Immunotherapy to Treat Glaucoma
por: Tonner, Henrik, et al.
Publicado: (2022)

Comparison of Two Solid-Phase Extraction (SPE) Methods for the Identification and Quantification of Porcine Retinal Protein Markers by LC-MS/MS
por: Schmelter, Carsten, et al.
Publicado: (2018)

Amyloid beta is an early responder cytokine and immunopeptide of the innate immune system
por: Weaver, Donald F.
Publicado: (2020)

Profound N-glycan remodelling accompanies MHC-II immunopeptide presentation
por: Goodson, Hayley, et al.
Publicado: (2023)

Comparative Quantitative Analysis of Porcine Optic Nerve Head and Retina Subproteomes
por: Funke, Sebastian, et al.
Publicado: (2019)

MS(2)Rescore: Data-Driven Rescoring Dramatically Boosts Immunopeptide Identification Rates
por: Declercq, Arthur, et al.
Publicado: (2022)

Neuroprotective and neuroregenerative effects of CRMP-5 on retinal ganglion cells in an experimental in vivo and in vitro model of glaucoma
por: Lauzi, Jasmin, et al.
Publicado: (2019)

Proteomics analysis of human tears from aqueous-deficient and evaporative dry eye patients
por: Perumal, Natarajan, et al.
Publicado: (2016)

The Small Heat Shock Protein α-Crystallin B Shows Neuroprotective Properties in a Glaucoma Animal Model
por: Anders, Fabian, et al.
Publicado: (2017)

First insight into the proteome landscape of the porcine short posterior ciliary arteries: Key signalling pathways maintaining physiologic functions
por: Manicam, Caroline, et al.
Publicado: (2016)

Antibody and Protein Profiles in Glaucoma: Screening of Biomarkers and Identification of Signaling Pathways
por: Auler, Nadine, et al.
Publicado: (2021)

Characterization of the human aqueous humour proteome: A comparison of the genders
por: Perumal, Natarajan, et al.
Publicado: (2017)

Serum and Antibodies of Glaucoma Patients Lead to Changes in the Proteome, Especially Cell Regulatory Proteins, in Retinal Cells
por: Bell, Katharina, et al.
Publicado: (2012)

γ-Synuclein Antibodies Have Neuroprotective Potential on Neuroretinal Cells via Proteins of the Mitochondrial Apoptosis Pathway
por: Wilding, Corina, et al.
Publicado: (2014)

Bioenergetic shift and actin cytoskeleton remodelling as acute vascular adaptive mechanisms to angiotensin II in murine retina and ophthalmic artery
por: Perumal, Natarajan, et al.
Publicado: (2020)

Modulation of the Immune System for the Treatment of Glaucoma
por: Bell, Katharina, et al.
Publicado: (2018)

Neuroprotection in glaucoma
por: Vasudevan, Sushil K, et al.
Publicado: (2011)

Neuroprotection in Glaucoma
por: Nilforushan, Naveed
Publicado: (2012)

Neuroprotection in Glaucoma
por: Doozandeh, Azadeh, et al.
Publicado: (2016)

Neuroprotection in glaucoma
por: Vishwaraj, C R, et al.
Publicado: (2022)

Mitochondria-Targeted Antioxidant SS-31 is a Potential Novel Ophthalmic Medication for Neuroprotection in Glaucoma
por: PANG, Yu, et al.
Publicado: (2015)

Longitudinal Analysis of Serum Autoantibody-Reactivities in Patients with Primary Open Angle Glaucoma and Optic Disc Hemorrhage
por: Lorenz, Katrin, et al.
Publicado: (2016)

Neurodegeneration and Neuroprotection in Glaucoma
por: Gauthier, Angela C., et al.
Publicado: (2016)

Neuroprotective therapies for glaucoma
por: Song, Wei, et al.
Publicado: (2015)

Neuroprotection in glaucoma-electrophysiology
por: Lešták, Ján, et al.
Publicado: (2020)

Current perspective of neuroprotection and glaucoma
por: Tian, Kailin, et al.
Publicado: (2015)

Neuroprotective agents in the management of glaucoma
por: Nucci, C., et al.
Publicado: (2018)

Proteomics Unravels the Regulatory Mechanisms in Human Tears Following Acute Renouncement of Contact Lens Use: A Comparison between Hard and Soft Lenses
por: Manicam, Caroline, et al.
Publicado: (2018)

Immune response after intermittent minimally invasive intraocular pressure elevations in an experimental animal model of glaucoma
por: Gramlich, Oliver W., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dunpvq6gdpfglk18c5piqh8vs3